| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.02. | This analyst just raised his price target on Electromed | 2 | Cantech Letter | ||
| 11.02. | Electromed signals continued double-digit revenue growth with 13th straight quarterly gains, highlighting expansion in bronchiectasis market | 1 | Seeking Alpha | ||
| 10.02. | Electromed GAAP EPS of $0.32 beats by $0.06, revenue of $18.9M beats by $0.85M | 1 | Seeking Alpha | ||
| 10.02. | Electromed, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 10.02. | Electromed, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 09.02. | What's Next: Electromed's Earnings Preview | 1 | Benzinga.com | ||
| 18.12.25 | Electromed, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.11.25 | Noble Financial Group, Inc.: Electromed, Inc. to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference | 403 | Newsfile | New Prague, Minnesota--(Newsfile Corp. - November 20, 2025) - Electromed, Inc. (NYSE American: ELMD) ("Electromed" or the "Company"), a leader in innovative airway clearance technologies, today announced... ► Artikel lesen | |
| ELECTROMED Aktie jetzt für 0€ handeln | |||||
| 18.11.25 | Electromed, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.11.25 | Electromed outlines ongoing double-digit growth and hospital channel expansion with 15% revenue increase | 4 | Seeking Alpha | ||
| 12.11.25 | Electromed: EPS übertrifft Schätzungen um 0,04 $ - Umsatz besser als erwartet | 2 | Investing.com Deutsch | ||
| 12.11.25 | Electromed GAAP EPS of $0.25 beats by $0.05, revenue of $16.9M beats by $0.27M | 1 | Seeking Alpha | ||
| 12.11.25 | Electromed, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 13.10.25 | Electromed, Inc. to Participate in LD Micro Main Event XIX | 389 | Newsfile | New Prague, Minnesota--(Newsfile Corp. - October 13, 2025) - Electromed, Inc. (NYSE American: ELMD) ("Electromed" or the "Company"), a leader in innovative airway clearance technologies, today announced... ► Artikel lesen | |
| 09.09.25 | Electromed authorizes $10 million share repurchase program | 1 | Investing.com | ||
| 09.09.25 | Electromed authorizes new $10M share repurchase program | 1 | Seeking Alpha | ||
| 09.09.25 | Electromed, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 09.06.25 | Electromed, Inc. to Present at the Investor Summit Virtual on June 10, 2025 | 249 | ACCESS Newswire | NEW PRAGUE, MN / ACCESS Newswire / June 9, 2025 / Electromed, Inc. announced that Jim Cunniff, President and Chief Executive Officer, will be presenting at the Investor Summit Virtual taking place on... ► Artikel lesen | |
| 03.04.25 | Electromed, Inc. to Present at the LD Micro Invitational XV | 412 | Newsfile | New Prague, Minnesota--(Newsfile Corp. - April 3, 2025) - Electromed, Inc. (NYSE American: ELMD) announced today that it will be participating in the 15th Annual LD Micro Invitational at the Westin... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 19,220 | -5,83 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,380 | 0,00 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,170 | -2,88 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,510 | +0,74 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 50,04 | -2,49 % | DAX-Check: BMW, Fresenius, Hochtief, MTU, Vonovia, Zalando | Donald Trump wirbelt die Märkte mal wieder durcheinander. Der US-Präsident kündigte neue globale Zölle an. Zuvor hatte der Supreme Court die bisherigen Zollmaßnahmen für unrechtmäßig erklärt. Die Unsicherheit... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 22,670 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance | SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PROGYNY | 17,685 | -20,55 % | Progyny, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| GENEDX | 79,77 | -1,87 % | These Analysts Slash Their Forecasts On GeneDx After Q4 Results | ||
| ONEMEDNET | 1,030 | 0,00 % | OneMedNet-Aktie steigt nach Plattform-Launch um 90 % | ||
| PRIVIA HEALTH GROUP | 23,730 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen | |
| GERRESHEIMER | 16,290 | +3,76 % | UBS stuft GERRESHEIMER AG auf 'Sell' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Gerresheimer von 29,00 auf 12,90 Euro eingestampft und die Aktien von "Neutral" auf "Sell" abgestuft. Olivier Calvet analysierte... ► Artikel lesen | |
| PACS GROUP | 36,475 | 0,00 % | Truist raises PACS Group stock price target to $50 on margin strength | ||
| CARL ZEISS MEDITEC | 26,320 | -3,52 % | Carl Zeiss Meditec AG: ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options | Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate - whether as a standalone cloud application or as an integrated... ► Artikel lesen | |
| ADAPTHEALTH | 9,155 | +0,94 % | Leerink cuts AdaptHealth stock price target on 2025 earnings decline | ||
| LIFESTANCE HEALTH GROUP | 7,240 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |